Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jasmina KapetanovicDr Jasmina Kapetanovic has been awarded an MRC Clinician Scientist Fellowship, for her research: 'New genetic therapy approaches for inherited retinal diseases.' The award will support her research on optimising the delivery and expression of genes in retinal disorders using latest technologies.

The focus of her research has been to use pre-clinical models to develop new treatments for inherited retinal degenerations, the commonest cause of blindness in working age population. One of the main obstacles in translating retinal genetic therapies is low efficiency of retinal vector transduction. To address this, the fellowship programme will develop innovative delivery strategies using robotic assistance to improve targeting of retinal neurons with gene therapy vectors. The project will also focus on optimising gene expression in mitochondria, for the treatment of optic neuropathies, and in inner retinal neurons for optogenetic applications to restore vision.

The MRC fellowship will allow her to establish her independent research programme within the Clinical Ophthalmology Research Group, and develop new treatments that can be applied directly to patients to prevent and restore sight loss.

Similar stories

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

Director of MRC Brain Network Dynamics Unit appointed

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.